Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society (ATS) 2025 International Conference.

AstraZeneca's Breztri Aerosphere in India is made using a new type of gas (called a next-generation propellant) that does not ...

The UK MHRA has approved AstraZeneca's Trixeo Aerosphere inhaler to treat adults with chronic obstructive pulmonary disease ...

AstraZeneca’s Trixeo Aerosphere approved in UK as first inhaled respiratory medicine using next-generation propellant with near-zero GWP: Cambridge, UK Tuesday, May 13, 2025, 09 ...

Tom Keith-Roach, president of AZ's UK business, said: "The UK approval of Trixeo Aerosphere with the [new] propellant marks a ...

Novo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with uncontrolled asthma in two phase 3 trials, according to a press ...

AstraZeneca has announced positive results from the Phase III KALOS and LOGOS clinical trials of Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) in ...

AstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that fixed-dose triple ...

AstraZeneca PLC (LSE/STO/Nasdaq:LON:AZN) announced today that its asthma treatment, Breztri Aerosphere, has met all primary endpoints in the Phase III KALOS and LOGOS trials. The trials demonstrated ...

WILMINGTON, Del. - AstraZeneca (Market cap: $219.79B), a prominent player in the pharmaceuticals industry with an "GREAT" financial health rating according to InvestingPro, announced its ...